In vitro diagnostics are tests done on samples such as blood or tissue that have been taken from the human body. In vitro diagnostics can detect diseases or other conditions, and can be used to monitor a personﾒs overall health to help cure, treat, or prevent diseases. In vitro diagnostics may also be used in precision medicine to identify patients who are likely to benefit from specific treatments or therapies. These in vitro diagnostics can include next generation sequencing tests, which scan a personﾒs DNA to detect genomic variations. Some tests are used in laboratory or other health professional settings and other tests are for consumers to use at home. This report aims to provide a comprehensive presentation of the global market for In-vitro Diagnostic Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In-vitro Diagnostic Services. This report contains market size and forecasts of In-vitro Diagnostic Services in global, including the following market information: Global In-vitro Diagnostic Services Market Revenue, 2018-2023, 2024-2029, ($ millions) Global top five companies in 2022 (%) The global In-vitro Diagnostic Services market was valued at US$ 66330 million in 2022 and is projected to reach US$ 88020 million by 2029, at a CAGR of 4.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million. Infectious Testing Segment to Reach $ Million by 2029, with a % CAGR in next six years. The global key manufacturers of In-vitro Diagnostic Services include BioRad, DexCom, Nova Biomedical, OraSure, Pearl Pathways, Phenomenex, Qiagen, Roche Diagnostics and Siemens, etc. in 2022, the global top five players have a share approximately % in terms of revenue. MARKET MONITOR GLOBAL, INC (MMG) has surveyed the In-vitro Diagnostic Services companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks. Total Market by Segment: Global In-vitro Diagnostic Services Market, by Type, 2018-2023, 2024-2029 ($ millions) Global In-vitro Diagnostic Services Market Segment Percentages, by Type, 2022 (%) Infectious Testing Diabetes Testing Molecular Testing Tissue Testing Global In-vitro Diagnostic Services Market, by Application, 2018-2023, 2024-2029 ($ millions) Global In-vitro Diagnostic Services Market Segment Percentages, by Application, 2022 (%) Hospitals Point-Of-Care Testing Laboratories Academic Institutes Global In-vitro Diagnostic Services Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) Global In-vitro Diagnostic Services Market Segment Percentages, By Region and Country, 2022 (%) North America US Canada Mexico Europe Germany France U.K. Italy Russia Nordic Countries Benelux Rest of Europe Asia China Japan South Korea Southeast Asia India Rest of Asia South America Brazil Argentina Rest of South America Middle East & Africa Turkey Israel Saudi Arabia UAE Rest of Middle East & Africa Competitor Analysis The report also provides analysis of leading market participants including: Key companies In-vitro Diagnostic Services revenues in global market, 2018-2023 (estimated), ($ millions) Key companies In-vitro Diagnostic Services revenues share in global market, 2022 (%) Further, the report presents profiles of competitors in the market, key players include: BioRad DexCom Nova Biomedical OraSure Pearl Pathways Phenomenex Qiagen Roche Diagnostics Siemens Sysmex Thermofisher Outline of Major Chapters: Chapter 1: Introduces the definition of In-vitro Diagnostic Services, market overview. Chapter 2: Global In-vitro Diagnostic Services market size in revenue. Chapter 3: Detailed analysis of In-vitro Diagnostic Services company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc. Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 6: Sales of In-vitro Diagnostic Services in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world. Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports 1.1 In-vitro Diagnostic Services Market Definition 1.2 Market Segments 1.2.1 Market by Type 1.2.2 Market by Application 1.3 Global In-vitro Diagnostic Services Market Overview 1.4 Features & Benefits of This Report 1.5 Methodology & Sources of Information 1.5.1 Research Methodology 1.5.2 Research Proc